Wells Fargo & Company MN Acquires 14,482 Shares of Orthofix International N.V. (NASDAQ:OFIX)

Wells Fargo & Company MN increased its holdings in shares of Orthofix International N.V. (NASDAQ:OFIX) by 109.2% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 27,749 shares of the medical device company’s stock after purchasing an additional 14,482 shares during the period. Wells Fargo & Company MN owned approximately 0.15% of Orthofix International worth $1,311,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also modified their holdings of the stock. Dimensional Fund Advisors LP grew its position in Orthofix International by 11.6% during the second quarter. Dimensional Fund Advisors LP now owns 870,120 shares of the medical device company’s stock valued at $40,443,000 after buying an additional 90,349 shares during the period. State Street Corp grew its position in Orthofix International by 4.1% during the second quarter. State Street Corp now owns 481,220 shares of the medical device company’s stock valued at $22,370,000 after buying an additional 18,741 shares during the period. Northern Trust Corp grew its position in Orthofix International by 5.8% during the second quarter. Northern Trust Corp now owns 350,019 shares of the medical device company’s stock valued at $16,269,000 after buying an additional 19,253 shares during the period. Teachers Advisors LLC grew its position in Orthofix International by 15.9% during the second quarter. Teachers Advisors LLC now owns 320,404 shares of the medical device company’s stock valued at $14,892,000 after buying an additional 44,064 shares during the period. Finally, JPMorgan Chase & Co. grew its position in Orthofix International by 4.5% during the third quarter. JPMorgan Chase & Co. now owns 245,495 shares of the medical device company’s stock valued at $11,654,000 after buying an additional 10,580 shares during the period. 95.78% of the stock is owned by hedge funds and other institutional investors.

Several analysts recently commented on the stock. Zacks Investment Research lowered shares of Orthofix International from a “buy” rating to a “hold” rating in a research report on Wednesday, November 8th. BidaskClub upgraded shares of Orthofix International from a “sell” rating to a “hold” rating in a research report on Thursday, December 21st. TheStreet lowered shares of Orthofix International from a “b” rating to a “c+” rating in a research report on Tuesday, October 31st. Finally, BTIG Research set a $56.00 target price on shares of Orthofix International and gave the company a “buy” rating in a research report on Monday, October 30th. Two analysts have rated the stock with a hold rating and five have given a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $54.42.

In related news, insider Bradley V. Niemann sold 5,547 shares of the business’s stock in a transaction dated Monday, December 11th. The shares were sold at an average price of $52.08, for a total transaction of $288,887.76. Following the transaction, the insider now directly owns 34,631 shares in the company, valued at $1,803,582.48. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Brad Mason sold 5,000 shares of the business’s stock in a transaction dated Tuesday, November 28th. The stock was sold at an average price of $53.48, for a total transaction of $267,400.00. Following the transaction, the chief executive officer now owns 183,053 shares in the company, valued at $9,789,674.44. The disclosure for this sale can be found here. 5.60% of the stock is owned by company insiders.

Shares of Orthofix International N.V. (OFIX) traded up $0.33 during midday trading on Wednesday, hitting $52.40. 75,735 shares of the stock traded hands, compared to its average volume of 151,959. Orthofix International N.V. has a 1-year low of $33.90 and a 1-year high of $58.22. The firm has a market capitalization of $952.39, a price-to-earnings ratio of 34.14, a price-to-earnings-growth ratio of 2.27 and a beta of 0.22.

COPYRIGHT VIOLATION WARNING: “Wells Fargo & Company MN Acquires 14,482 Shares of Orthofix International N.V. (NASDAQ:OFIX)” was first reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this news story on another domain, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The original version of this news story can be accessed at https://www.dispatchtribunal.com/2018/02/14/wells-fargo-company-mn-acquires-14482-shares-of-orthofix-international-n-v-ofix.html.

Orthofix International Profile

Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.

Institutional Ownership by Quarter for Orthofix International (NASDAQ:OFIX)

Receive News & Ratings for Orthofix International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply